Connection

EDWARD MASON to Drug Synergism

This is a "connection" page, showing publications EDWARD MASON has written about Drug Synergism.
Connection Strength

0.043
  1. In vitro synergy of ampicillin and chloramphenicol against gram-negative bacteria. Pediatr Pharmacol (New York). 1981; 1(4):305-11.
    View in: PubMed
    Score: 0.011
  2. In vitro susceptibility of 104 clinical isolates of Haemophilus influenzae to moxalactam (LY127935), ampicillin, chloramphenicol, and ticarcillin. Antimicrob Agents Chemother. 1980 Mar; 17(3):470-3.
    View in: PubMed
    Score: 0.010
  3. In vitro antibiotic synergy against Flavobacterium meningosepticum: implications for therapeutic options. Clin Infect Dis. 1998 May; 26(5):1169-76.
    View in: PubMed
    Score: 0.009
  4. Activity of oral antibiotics in middle ear and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: implications for treatment. Pediatr Infect Dis J. 1994 Jul; 13(7):585-9.
    View in: PubMed
    Score: 0.007
  5. Use of intravenous rifampin in neonates with persistent staphylococcal bacteremia. Antimicrob Agents Chemother. 1993 Nov; 37(11):2401-6.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.